Skip to content
Careers
Contacts
Menu
Close
Profile
About Transgene
Management Team
Board of Directors
Scientific advisors
Corporate governance
Ethics & compliance
Collaborations
Partners
Technology
Viral-based Immunotherapies
Individualized neoantigen cancer vaccines
Shared antigens cancer vaccines
Oncolytic Viruses
myvac Platform
Invir.IO Platform
Publications and Presentations
Portfolio
Pipeline
TG4050
TG4001
TG6050
BT-001
Clinical trials FAQ
Investors
Financial Information
Stock Information
Investor Events & Presentation
Annual General Meeting
Press Releases
Category:
News
Transgene Announces Upcoming Investor Meetings
Transgene Announces Upcoming Investor Meetings
Next Annual General Meeting on 24 May 2016
documents
Interview with Philippe Archinard on TV Finance
interview
June 17, 2014 – Letter to shareholders